| 660058 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA |
2021-03-01 |
10.1136/jitc-2020-001935 |
Kalinich Mark, Murphy William, Wongvibulsin Shannon, Pahalyants Vartan, Yu Kun-Hsing, Lu Chenyue, Wang Feicheng, Zubiri Leyre, Naranbhai Vivek, Gusev Alexander, Kwatra Shawn G, Reynolds Kerry L, Semenov Yevgeniy R |
| 660057 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways |
2021-03-01 |
10.1136/jitc-2021-002355 |
Cecil Denise, Park Kyong Hwa, Curtis Benjamin, Corulli Lauren, Disis Mary (Nora) |
| 660056 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients |
2021-03-01 |
10.1136/jitc-2020-001458 |
Starzer Angelika M, Berghoff Anna S, Hamacher Rainer, Tomasich Erwin, Feldmann Katharina, Hatziioannou Teresa, Traint Stefan, Lamm Wolfgang, Noebauer-Huhmann Iris M, Furtner Julia, Müllauer Leonhard, Amann Gabriele, Bauer Sebastian, Schildhaus Hans-Ulrich, Preusser Matthias, Heller Gerwin, Brodowicz Thomas |
| 660055 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy |
2021-03-01 |
10.1136/jitc-2020-001966 |
Hubert Pascale, Roncarati Patrick, Demoulin Stephanie, Pilard Charlotte, Ancion Marie, Reynders Celia, Lerho Thomas, Bruyere Diane, Lebeau Alizee, Radermecker Coraline, Meunier Margot, Nokin Marie-Julie, Hendrick Elodie, Peulen Olivier, Delvenne Philippe, Herfs Michael |
| 660054 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer |
2021-03-01 |
10.1136/jitc-2020-001813 |
Kießler Maximilian, Plesca Ioana, Sommer Ulrich, Wehner Rebekka, Wilczkowski Friederike, Müller Luise, Tunger Antje, Lai Xixi, Rentsch Anke, Peuker Kenneth, Zeissig Sebastian, Seifert Adrian M, Seifert Lena, Weitz Jürgen, Bachmann Michael, Bornhäuser Martin, Aust Daniela, Baretton Gustavo, Schmitz Marc |
| 660053 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC) |
2021-03-01 |
10.1136/jitc-2021-002374 |
Bilusic Marijo, McMahon Sheri, Madan Ravi A, Karzai Fatima, Tsai Yo-Ting, Donahue Renee N, Palena Claudia, Jochems Caroline, Marté Jennifer L, Floudas Charalampos, Strauss Julius, Redman Jason, Abdul Sater Houssein, Rabizadeh Shahrooz, Soon-Shiong Patrick, Schlom Jeffrey, Gulley James L |
| 660052 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma |
2021-03-01 |
10.1136/jitc-2020-002009 |
Chehrazi-Raffle Alexander, Meza Luis, Alcantara Marice, Dizman Nazli, Bergerot Paulo, Salgia Nicholas, Hsu JoAnn, Ruel Nora, Salgia Sabrina, Malhotra Jasnoor, Karczewska Ewa, Kortylewski Marcin, Pal Sumanta |
| 660051 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer |
2021-03-01 |
10.1136/jitc-2020-002068 |
Melisi Davide, Oh Do-Youn, Hollebecque Antoine, Calvo Emiliano, Varghese Anna, Borazanci Erkut, Macarulla Teresa, Merz Valeria, Zecchetto Camilla, Zhao Yumin, Gueorguieva Ivelina, Man Michael, Gandhi Leena, Estrem Shawn T, Benhadji Karim A, Lanasa Mark C, Avsar Emin, Guba Susan C, Garcia-Carbonero Rocio |
| 660050 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC |
2021-03-01 |
10.1136/jitc-2020-001506 |
Ross-Macdonald Petra, Walsh Alice M, Chasalow Scott D, Ammar Ron, Papillon-Cavanagh Simon, Szabo Peter M, Choueiri Toni K, Sznol Mario, Wind-Rotolo Megan |
| 660049 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer |
2021-03-01 |
10.1136/jitc-2020-001865 |
Ardizzoni Andrea, Azevedo Sergio, Rubio-Viqueira Belen, Rodríguez-Abreu Delvys, Alatorre-Alexander Jorge, Smit Hans J M, Yu Jinming, Syrigos Konstantinos, Trunzer Kerstin, Patel Hina, Tolson Jonathan, Cardona Andres, Perez-Moreno Pablo D, Newsom-Davis Tom |
